碘对比剂相关肠壁血管性水肿:发生率与易感因素
回顾性匹配队列研究显示,CT检查中碘对比剂相关肠壁血管性水肿在既往有对比剂不良反应史的患者中发生率为3.3%(按患者)和2.6%(按检查),在无不良反应史匹配患者中为1.9%和1.7%,两组间无显著差异(P=0.346和P=0.370)。病变累及远端十二指肠和/或近端空肠,CT上表现为长段环形肠壁增厚。所研究的易感因素均与肠壁血管性水肿无关(P>0.05)。
要点
- 有对比剂不良反应史患者中,碘对比剂相关肠壁血管性水肿发生率为3.3%(14/427,按患者)。
- 病变典型位置为远端十二指肠和/或近端空肠,CT表现为长段环形肠壁增厚。
- 有不良反应史组与无不良反应史匹配组间发生率无显著差异(P=0.346和P=0.370)。
核心结论
- CT检查中碘对比剂相关肠壁血管性水肿发生率为1.7%至3.3%,所研究的易感因素均与肠壁血管性水肿无关。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并豁免知情同意;2013年7月至2015年7月,纳入有CT碘对比剂不良反应史的成年患者(A组,n=427)和按年龄、性别经倾向评分匹配的无不良反应患者(B组,n=427);对比剂相关肠壁血管性水肿定义为增强后肠壁厚度较平扫增加。
关键影像表现/征象
- CT上表现为长段环形肠壁增厚,累及远端十二指肠和/或近端空肠。
诊断标准与关键数值
- 对比剂相关肠壁血管性水肿判定标准:增强后肠壁厚度较平扫增加。
- A组发生率:按患者分析3.3%(14/427),按检查分析2.6%(15/578)。
- B组发生率:按患者分析1.9%(8/427),按检查分析1.7%(8/458)。
- A组与B组发生率比较:按患者P=0.346,按检查P=0.370,均无显著差异。
临床应用与阅片要点
- 在增强CT中观察到远端十二指肠和/或近端空肠长段环形肠壁增厚时,可提示碘对比剂相关肠壁血管性水肿可能。
- 所研究的患者人口学、症状及不良反应时间、对比剂相关因素均与肠壁血管性水肿无关(P>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Bowel angioedema is an acute adverse reaction to iodinated contrast media (CM) that involves the gastrointestinal tract. We aimed to investigate the incidence and predisposing factors of iodinated CM-associated bowel angioedema during computed tomography (CT) examinations.
MATERIALS AND METHODS: This study was approved by our institutional review board, and informed consent was waived due to its retrospective design. From July 2013 to July 2015, adult patients with a history of adverse reactions to iodinated CM during CT (group A, n = 427) and patients without adverse reactions matched for age and sex with the propensity-score matching method (group B, n = 427) were studied. Contrast media-associated bowel angioedema was determined when bowel wall thickness increased after contrast enhancement compared with the precontrast scan. Potential predisposing factors including patient demographics, symptoms and time of adverse reactions, and CM-related factors were compared between patients with and without angioedema in group A. In addition, the incidence of bowel angioedema was compared between groups A and B.
RESULTS: The incidence of CM-associated bowel angioedema in group A was 3.3% (14/427) in the per-patient analysis and 2.6% (15/578) in the per-examination analysis. The CM-associated bowel angioedema involved the distal duodenum and/or proximal jejunum and showed long-segmental circumferential bowel wall thickening on CT. None of the studied predisposing factors was different between patients with and without bowel angioedema (P > 0.05). The incidence of CM-associated bowel angioedema in group B was 1.9% (8/427) and 1.7% (8/458) for per-patient and per-examination analyses, respectively, and these rates were not significantly different between groups A and B (P = 0.346 and P = 0.370, respectively).
CONCLUSIONS: The incidence of CM-associated bowel angioedema during CT was 1.7% to 3.3%, and none of the studied predisposing factors was associated with bowel angioedema.
引用
- Seo N, Chung YE, Lim JS, et al. Bowel Angioedema Associated With Iodinated Contrast Media: Incidence and Predisposing Factors. Invest Radiol. 2017. PMID: 28368879. doi:10.1097/RLI.0000000000000371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。